Author

Olivia Hentic

Observed names: HENTIC, Olivia, Hentic, O, Hentic, O., Hentic, Olivia, O Hentic, O Hentic-Dhomé, O. Hentic, O. Hentic Dhome, O. Hentic-Dhomé, Olivia Hentic Dhome, Olivia Hentic-Dhome, Olivia Hentic-Dhomé, olivia Hentic

Observed institutions: Inserm, Université Paris Cité, Trinity College Dublin, Hôpital Beaujon, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Centre de Recherche sur l'Inflammation, Hôpital Bichat-Claude-Bernard, St. James's Hospital, Université Paris Diderot

ORCID: 0009-0003-5402-8797

Observed ORCID: 0009-0003-5402-8797

OpenAlex ID: A5008482986

The natural history of hereditary pancreatitis: a national series

2008 · V Rebours, M-C Boutron-Ruault, et al. · Gut · 306

PDF

Neuroendocrine tumors of midgut and hindgut origin: Tumor‐node‐metastasis classification determines clinical outcome

2011 · Henning Jann, Stephanie Roll, et al. · Cancer · 289

PDF

Pancreas Divisum Is Not a Cause of Pancreatitis by Itself But Acts as a Partner of Genetic Mutations

2011 · Caroline Bertin, Anne-Laure Pelletier, et al. · The American Journal of Gastroenterology · 251

Pancreatic Endocrine Tumors: Tumor Blood Flow Assessed with Perfusion CT Reflects Angiogenesis and Correlates with Prognostic Factors1

2008 · Gaspard d'Assignies, Anne Couvelard, et al. · Radiology · 246

Natural History of Intraductal Papillary Mucinous Tumors of the Pancreas: Actuarial Risk of Malignancy

2006 · Philippe Lévy, Vincent Jouannaud, et al. · Clinical Gastroenterology and Hepatology · 240

PDF

Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis

2010 · Frédérique Maire, Yann Le Baleur, et al. · The American Journal of Gastroenterology · 189

Long-term Outcome of Biliary and Duodenal Stents in Palliative Treatment of Patients with Unresectable Adenocarcinoma of the Head of Pancreas

2006 · Frédérique Maire, Pascal Hammel, et al. · The American Journal of Gastroenterology · 181

FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide–platinum combination in patients with neuroendocrine carcinomas grade 3

2012 · O Hentic, P Hammel, et al. · Endocrine Related Cancer · 162

PDF

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

2020 · Astrid Lièvre, Anthony Turpin, et al. · European Journal of Cancer · 161

PDF

Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms

2017 · Louis de Mestier, Jérôme Cros, et al. · Neuroendocrinology · 160

Two-step Surgery for Synchronous Bilobar Liver Metastases From Digestive Endocrine Tumors: A Safe Approach for Radical Resection

2008 · Reza Kianmanesh, Alain Sauvanet, et al. · Annals of Surgery · 126

Morphologic Changes in Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Midterm Follow-Up Study

2008 · Pierre—Emmanuel Rautou, Phillippe Lévy, et al. · Clinical Gastroenterology and Hepatology · 114

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

2017 · T. Walter, D. Tougeron, et al. · European Journal of Cancer · 113

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors

2016 · J Cros, O Hentic, et al. · Endocrine Related Cancer · 112

PDF

Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study

2012 · Frédérique Maire, Catherine Lombard-Bohas, et al. · Neuroendocrinology · 111

The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas

2012 · Wafaa Khannoussi, Marie Pierre Vullierme, et al. · Pancreatology · 109

Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours

2006 · F Marrache, M P Vullierme, et al. · British Journal of Cancer · 107

PDF

Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging

2016 · Emad Lotfalizadeh, Maxime Ronot, et al. · European Radiology · 98

Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors

2008 · Anne Couvelard, Lydia Deschamps, et al. · Modern Pathology · 95

How Does Chemoradiotherapy Following Induction FOLFIRINOX Improve the Results in Resected Borderline or Locally Advanced Pancreatic Adenocarcinoma? An AGEO-FRENCH Multicentric Cohort

2018 · Daniel Pietrasz, Olivier Turrini, et al. · Annals of Surgical Oncology · 89

Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial

2022 · Stefano Partelli, Sara Massironi, et al. · British journal of surgery · 88

PDF

Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort

2015 · Daniel Pietrasz, Lysiane Marthey, et al. · Annals of Surgical Oncology · 84

Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery

2015 · Sophie Lardière-Deguelte, Louis de Mestier, et al. · Neuroendocrinology · 83

Chemotherapy for Gastro-Enteropancreatic Endocrine Tumours

2004 · Dermot O’Toole, Olivia Hentic, et al. · Neuroendocrinology · 83

Mucinous Cystic Neoplasms of the Pancreas: Definition of Preoperative Imaging Criteria for High-Risk Lesions

2011 · Yann Le Baleur, Anne Couvelard, et al. · Pancreatology · 78

Works count: 272

Citation count: 6,438

H-index: 50

I10-index: 97